186 related articles for article (PubMed ID: 6293813)
1. In vitro activity of ceftazidime, cefotaxime and piperacillin against multi-resistant gram-negative bacteria tested with a modified agar dilution method.
Hoogkamp-Korstanje JA; Meijer CA
Eur J Clin Microbiol; 1982 Jun; 1(3):166-70. PubMed ID: 6293813
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of BRL 36650, a new penicillin.
Van Landuyt HW; Lambert A; Boelaert J; Gordts B
Antimicrob Agents Chemother; 1986 Feb; 29(2):362-6. PubMed ID: 3087281
[TBL] [Abstract][Full Text] [Related]
3. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
Thabaut A; Meyran M; Huerre M
Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
[TBL] [Abstract][Full Text] [Related]
4. Ceftazidime: comparative in-vitro study.
Verbist L; Verhaegen J
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():67-71. PubMed ID: 19802971
[TBL] [Abstract][Full Text] [Related]
5. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
Kurtz TO; Winston DJ; Hindler JA; Young LS; Hewitt WL; Martin WJ
Antimicrob Agents Chemother; 1980 Oct; 18(4):645-8. PubMed ID: 6255864
[TBL] [Abstract][Full Text] [Related]
7. Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
Magnussen CR; Sammartino MT; Ernest KD
Antimicrob Agents Chemother; 1982 Jul; 22(1):154-6. PubMed ID: 6289736
[TBL] [Abstract][Full Text] [Related]
8. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.
van Klingeren B
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():97-105. PubMed ID: 19810171
[TBL] [Abstract][Full Text] [Related]
9. The in-vitro activity of ceftazidime against clinically important pathogens.
Knothe H; Dette GA
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():33-41. PubMed ID: 19810167
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro inhibitory and killing activity of cefpirome, ceftazidime, and cefotaxime against Pseudomonas aeruginosa, enterococci, Staphylococcus epidermidis, and methicillin-susceptible and -resistant and tolerant and nontolerant Staphylococcus aureus.
Goldstein EJ; Citron DM
Antimicrob Agents Chemother; 1985 Jul; 28(1):160-2. PubMed ID: 3929677
[TBL] [Abstract][Full Text] [Related]
11. [In vitro activity of six beta-lactams against 295 strains of enterobacteriaceae and P. aeruginosa isolated from neutropenic patients].
Maugein J; Perrier F; Cony Makhoul P; Fourche J; Darmaillac V
Pathol Biol (Paris); 1995 Apr; 43(4):253-7. PubMed ID: 7567110
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial properties of imipenem with special reference to the activity against methicillin-resistant staphylococci, cefotaxime-resistant Enterobacteriaceae and Pseudomonas aeruginosa.
Vurma-Rapp U; Kayser FH; Barberis-Maino L
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():27-33. PubMed ID: 3102452
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of piperacillin and other microbials on 491 bacterial isolates.
Reeves DS
Arch Intern Med; 1982 Oct; 142(11):2023-32. PubMed ID: 6215009
[TBL] [Abstract][Full Text] [Related]
14. In vitro antibacterial activity of cefpiramide.
Pfaller MA; Niles AC; Murray PR
Antimicrob Agents Chemother; 1984 Mar; 25(3):368-72. PubMed ID: 6426381
[TBL] [Abstract][Full Text] [Related]
15. The in vitro antibacterial activity of ceftriaxone in comparison with nine other antibiotics.
Emmerson AM; Lamport PA; Reeves DS; Bywater MJ; Holt HA; Wise R; Andrews J; Hall MJ
Curr Med Res Opin; 1985; 9(7):480-93. PubMed ID: 3928265
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of BRL-36650, a novel beta-lactamase-stable penicillin, against multiply resistant gram-negative organisms.
Verbist L
J Antimicrob Chemother; 1986 Sep; 18(3):351-8. PubMed ID: 3095299
[TBL] [Abstract][Full Text] [Related]
17. [Comparative activity of azlocillin on Pseudomonas species excluding Pseudomonas aeruginosa].
Monteil H; Peladan F; Zinsius M
Presse Med; 1984 Mar; 13(13):780-4. PubMed ID: 6324160
[TBL] [Abstract][Full Text] [Related]
18. [In vitro studies with piperacillin. Effectiveness against enterobacteriaceae and pseudomonas aeruginosa compared to other antibiotics (author's transl)].
Baier R; Puppel H
Med Klin; 1979 Dec; 74(50):1923-7. PubMed ID: 120489
[TBL] [Abstract][Full Text] [Related]
19. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
Le Noc P; Bryskier A; Le Noc D
Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of HR 810, a new broad-spectrum cephalosporin.
Machka K; Braveny I
Eur J Clin Microbiol; 1983 Aug; 2(4):345-9. PubMed ID: 6313358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
